US Housing is rebounding — really

It's easy to be seduced by the doom and gloom, but there are signs that the worst hit of US sectors is recovering

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

US homebuilder stocks have been on a pretty steady incline this year, despite concerns about whether the housing market is truly recovering. Although recent news has still been a bit mixed, the upshot is that the US housing market really is improving, and there are concrete numbers to prove it.

Lennar (NYSE: LEN), one of the nation's largest home construction companies, reported a 33% increase in new home orders in the first quarter, as well as wider operating margins due to the ability of the company to reduce incentives and raise prices. CEO Stuart Miller's comments that stability was returning to the sector may sound trite, but the homebuilder's numbers seem to be proof. Its stock has been rising steadily, by nearly 60% from this time last year. Lest you think that this could be the result of wishful thinking on the part of investors, Lennar's first quarter easily beat analysts' estimates on EPS and revenue.

Ryland Group (NYSE: RYL) also has investor support, and, despite missing on revenue estimates, still delivered a revenue increase of almost 30% year over year. Other nuggets contained in its first-quarter report were an increase in new orders from the previous year of more than 46%, while closings rose 25% over the same time period.

Standard Pacific (NYSE: SPF), whose stock has risen 69% so far this year, also turned in numbers to die for: new orders up 43% from last year, an increase in backlog of 55%, and a revenue jump of nearly 56%. M.D.C. Holdings (NYSE: MDC) was equally upbeat, easily besting predictions in its own first-quarter report. New orders and backlog were up here as well, by 51% and 50%, respectively. Closings were up also, by 12%.

The increase in sale closings is significant, and it is noteworthy that a Wells Fargo survey for the month of March showed that both pricing and sales rates improved from February. A report from the US National Association of Realtors reinforces this point, noting that the number of properties that had signed purchase and sale agreements rose more than 4% from February, and nearly 13% from March 2011. Although the report didn't designate sales that had actually closed, the data shows that the market is moving in the right direction.

Fool's take
The evidence indicates quite clearly that a housing rebound has begun, and is gaining momentum. There may be a few more sputters and stalls, however, before the recovery gets a firm footing. Things are not all sweetness and light just yet, and a National Association of Home Builders report published in mid-April notes that builders' confidence in completed sales is still shaky, and that headwinds such as the still-high levels of foreclosures on the market and tight credit policies are still affecting the sector. The prime selling season is upon us, however, and it looks as if it just may be the best one we've seen for several years.

If you're looking in the market for some high yielding ASX shares, look no further than "Secure Your Future with 3 Rock-Solid Dividend Stocks". In this free report, we've put together our best ideas for investors who are looking for solid companies with high dividends and good growth potential. Click here now to find out the names of our three favourite income ideas. But hurry – the report is free for only a limited time.

More reading

The Motley Fool's purpose is to help the world invest, better. Take Stock is The Motley Fool's free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. Click here now to request your free subscription, whilst it's still available. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

A version of this article, written by Amanda Alix, originally appeared on fool.com

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »